Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma patients with haemophilia-Reference-Cited by-同舟云学术

Safety and efficacy of percutaneous radiofrequency ablation for hepatocellular carcinoma patients with haemophilia

Published:2020-11-27 Issue:1 Volume:27 Page:100-107
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Yamamoto Takafumi¹^ORCID,Imai Norihiro¹^ORCID,Yamamoto Kenta¹,Ito Takanori¹,Ishizu Yoji¹,Honda Takashi¹,Okamoto Shuichi²^ORCID,Kanematsu Takeshi³,Suzuki Nobuaki⁴^ORCID,Matsushita Tadashi³⁴,Ishigami Masatoshi¹,Fujishiro Mitsuhiro¹

Affiliation:

1. Department of Gastroenterology and Hepatology Nagoya University Graduate School of Medicine Nagoya‐shi Japan

2. Department of Hematology and Oncology Nagoya University Graduate School of Medicine Nagoya‐shi Japan

3. Department of Clinical Laboratory Nagoya University Hospital Nagoya‐shi Japan

4. Department of Transfusion Medicine Nagoya University Hospital Nagoya‐shi Japan

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.14220

Reference24 articles.

1. Incidence and risk factors for hepatocellular cancer in individuals with haemophilia: A National Inpatient Sample Study

2. High risk of non-A non-B hepatitis after a first exposure to volunteer or commercial clotting factor concentrates: effects of prophylactic immune serum globulin

3. Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study

5. Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical course and prognosis of patients with hepatocellular carcinoma and haemophilia;European Journal of Gastroenterology & Hepatology;2023-08-14

2. The influence of hepatitis C virus eradication on hepatocarcinogenesis in patients with hemophilia;Annals of Hepatology;2022-01

3. Tolerability of Molecular-targeted Agents for Hepatocellular Carcinoma Treatment in Haemophiliacs;Anticancer Research;2021-05